← Back to all trials
Active Not Recruiting
NCT06817382
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)
Conditions: Duchenne Muscular Dystrophy
Sex: Male
Ages: 2 Years – 4 Years
Healthy volunteers: No
Phase: PHASE1
Enrollment: 12
Sponsor: Insmed Gene Therapy LLC
Location: USA012 Little Rock Arkansas
Summary
The primary objective of this study is to evaluate the safety and tolerability of a single dose of INS1201 via IT administration in ambulatory male participants with DMD.
Eligibility Criteria
Inclusion Criteria
* Participant must be male at birth, 3 to \
Source: ClinicalTrials.gov (NCT06817382). StuddyBuddy aggregates publicly available trial information.
